Light Mode
$0.7097 ↑ +0.0275 (+4.03%) Trading Up from the previous close of $0.6822, $0.0403 below the day’s high of $0.7500
-1.59 (-67.94%) / 6M
Momentum, market sentiment, and recent alerts
CNTB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -50.6%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.